S11 Ep20: FDA Approval Insights: Perioperative Durvalumab for Resectable NSCLC
OncLive® On Air - Un pódcast de OncLive® On Air
Drs Patel and Stiles discuss the significance of the FDA approval of perioperative durvalumab for patients with resectable non–small cell lung cancer.
